Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment. - Suppr | 超能文献

Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment.

作者信息

Deuter Christoph M E, Kötter Ina, Günaydin Ilhan, Zierhut Manfred, Stübiger Nicole

机构信息

Department I, University Eye Hospital, Tübingen, Germany.

出版信息

Adv Exp Med Biol. 2003;528:525-8. doi: 10.1007/0-306-48382-3_105.

DOI:10.1007/0-306-48382-3_105

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment.

Adv Exp Med Biol. 2003;528:525-8. doi: 10.1007/0-306-48382-3_105.

2

Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a.

Adv Exp Med Biol. 2003;528:529-32. doi: 10.1007/0-306-48382-3_106.

3

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.人重组干扰素α-2a用于治疗伴有威胁视力的后部或全葡萄膜炎的白塞病。

Br J Ophthalmol. 2003 Apr;87(4):423-31. doi: 10.1136/bjo.87.4.423.

4

High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.高剂量甲氨蝶呤治疗白塞病眼部病变。初步短期结果。

Adv Exp Med Biol. 2003;528:579-84. doi: 10.1007/0-306-48382-3_118.

5

Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.用于治疗伴有威胁视力的视网膜血管炎的白塞病的人重组干扰素-α2a（rhIFN α2a）

Adv Exp Med Biol. 2003;528:521-3. doi: 10.1007/0-306-48382-3_104.

6

Efficacy of corticosteroids and cyclosporin in the treatment of retinal vasculitis in patients with Behçet's disease.

Adv Exp Med Biol. 2003;528:563-5. doi: 10.1007/0-306-48382-3_114.

7

[Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a].[白塞病的眼部受累：α-2a干扰素治疗后视觉发育的首个5年结果]

Ophthalmologe. 2004 Feb;101(2):129-34. doi: 10.1007/s00347-003-0927-7.

8

Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.硫唑嘌呤和低剂量脉冲环磷酰胺治疗白塞病严重眼部病变：初步报告

Adv Exp Med Biol. 2003;528:571-3. doi: 10.1007/0-306-48382-3_116.

9

Effect of infliximab on threatening panuveitis in Behçet's disease.英夫利昔单抗对白塞病威胁性全葡萄膜炎的疗效。

Lancet. 2001 Nov 10;358(9293):1644. doi: 10.1016/S0140-6736(01)06677-6.

10

Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.脉冲环磷酰胺和硫唑嘌呤联合治疗 Behcet 病眼部表现：长达 10 年的纵向研究。

Int J Rheum Dis. 2014 May;17(4):444-52. doi: 10.1111/1756-185X.12248. Epub 2013 Dec 8.

引用本文的文献

1

Interferon-alpha-associated presumed ocular sarcoidosis.干扰素α相关的疑似眼部结节病

Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):675-80. doi: 10.1007/s00417-008-1002-5. Epub 2008 Nov 26.

2

Management of sight-threatening uveitis: new therapeutic options.威胁视力的葡萄膜炎的管理：新的治疗选择。

Drugs. 2005;65(4):497-519. doi: 10.2165/00003495-200565040-00005.